National Express on track for full year

Bus and train group National Express said it is on target to deliver full year results in line with company expectations despite challenging conditions.

Bus and train group National Express said it is on target to deliver full year results in line with company expectations despite challenging conditions.

In an update on trading ahead of its year end on December 31st 2012 the group said UK Bus revenue increased 4% in the year to date while core revenue from non-concession passengers increased 2%.

In rail it said c2c has driven good revenue growth and has also recently pre-qualified for a fifth rail bid in Germany.

Total revenue growth at Alsa in the year to date is 3% while North American revenue grew by 3%.

Chief Executive Dean Finch commented: "The group remains on course to deliver its 2012 targets, despite the significant challenges of prevailing economic conditions and government austerity measures."

"Recent bid wins from an expanding pipeline of opportunities, combined with strong cash generation, underpin our platform for growth in the medium term."

National Express said its financial position remains robust.

"With the group's recent investment programme complete and a focus on capital-light development opportunities, we are driving strong cash generation and free cash flow across our businesses," the group said.

CJ

Recommended

Share tips of the week – 19 August
Share tips

Share tips of the week – 19 August

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
19 Aug 2022
How to invest in smart factories as the “fourth industrial revolution” arrives
Share tips

How to invest in smart factories as the “fourth industrial revolution” arrives

Exciting new technologies and trends are coming together to change the face of manufacturing. Matthew Partridge looks at the companies that will drive…
18 Aug 2022
How to invest today? Look to the past, not the future
Investment strategy

How to invest today? Look to the past, not the future

The past few years have seen so many changes to our way of life that many people said we had entered a “new normal”. But as it turns out, the new norm…
18 Aug 2022
A new legal headache for Haleon
Stocks and shares

A new legal headache for Haleon

Haleon, GSK’s former consumer-products arm, spun off last month, has made a dismal debut on the stockmarket.
17 Aug 2022

Most Popular

How to protect your wealth as inflation hits new record highs
Investment strategy

How to protect your wealth as inflation hits new record highs

UK inflation has hit a new record high of 10.1%. It's going to hurt, says Dominic Frisby. Here's how you can protect your wealth.
17 Aug 2022
How to cut your energy bill
Personal finance

How to cut your energy bill

The energy-price cap will almost double in the autumn. What does this mean for your money, and how can you alleviate the squeeze? Ruth Jackson-Kirby h…
17 Aug 2022
Are GSK’s legal troubles a threat to the firm’s survival?
Biotech stocks

Are GSK’s legal troubles a threat to the firm’s survival?

Pharmaceutical giant GlaxoSmithKline is facing legal action over heartburn drug Zantac that has seen billions wiped off its market value. Rupert Hargr…
16 Aug 2022